Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 70.01B | 67.73B | 56.79B | 49.98B | 44.06B |
Gross Profit | 17.98B | 16.35B | 13.40B | 11.87B | 11.07B |
EBITDA | 5.81B | 7.30B | 5.50B | 4.69B | 5.18B |
Net Income | 2.81B | 3.60B | 2.48B | 1.52B | 2.38B |
Balance Sheet | |||||
Total Assets | 70.85B | 69.39B | 60.16B | 54.30B | 53.24B |
Cash, Cash Equivalents and Short-Term Investments | 21.90B | 18.94B | 18.02B | 14.77B | 14.25B |
Total Debt | 5.31B | 5.75B | 5.53B | 5.15B | 4.94B |
Total Liabilities | 22.37B | 25.07B | 21.12B | 18.77B | 18.56B |
Stockholders Equity | 45.51B | 41.56B | 36.65B | 33.39B | 31.97B |
Cash Flow | |||||
Free Cash Flow | 3.92B | 3.95B | 3.06B | 988.00M | 3.35B |
Operating Cash Flow | 5.71B | 5.33B | 4.17B | 2.10B | 4.32B |
Investing Cash Flow | -1.38B | -3.90B | -2.51B | -1.46B | -1.81B |
Financing Cash Flow | -1.45B | -1.70B | -482.00M | -1.69B | -574.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥24.83B | 8.68 | 2.58% | 3.37% | -21.94% | ||
73 Outperform | ¥21.68B | 7.55 | 3.55% | 7.61% | -32.07% | ||
73 Outperform | ¥17.53B | 8.28 | 3.96% | -3.83% | 4.11% | ||
72 Outperform | ¥28.66B | 8.54 | 5.15% | -0.98% | 26.26% | ||
66 Neutral | $2.68B | 14.07 | 10.02% | 3.69% | -0.97% | 33.74% | |
63 Neutral | ¥26.12B | 17.89 | 3.26% | 5.69% | 202.27% | ||
59 Neutral | ¥7.23B | 19.70 | 3.03% | 0.66% | 41.70% |